Upload Avatar (500 x 500)
Zheng Yang
Medical School
Wuhan University
Hubei
Language: Chinese, English
Heart Failure
Cardiac Remodeling
Pathophysiology
Clinical Prevention
Interventional Diagnosis
Cardiovascular Diseases
Treatment
Cardiology
Research
Clinical Practice
Areas of Focus
- Heart failure and cardiac remodeling pathophysiology and clinical prevention
- Interventional diagnosis and treatment of cardiovascular diseases
Work Experience
- 2014.07-2014.11 Resident Physician, Cardiovascular Department, Renmin Hospital, Wuhan University
- 2014.12-2018.10 Attending Physician, Cardiovascular Department, Renmin Hospital, Wuhan University
- 2018.11-present Associate Chief Physician, Cardiovascular Department, Renmin Hospital, Wuhan University
- 2021.05-present Associate Professor, Cardiovascular Department, Renmin Hospital, Wuhan University
Academic Background & Achievements
- 2003-2008 Bachelor of Clinical Medicine from Capital Medical University
- 2008-2011 Master of Internal Medicine from Beijing Institute of Heart, Lung and Blood Vessel Diseases
- 2011-2014 PhD in Internal Medicine from Wuhan University First Clinical College
- Has presided over multiple research grants including the National Natural Science Foundation
Publications
- Aucubin Protects against Myocardial Infarction-Induced Cardiac Remodeling via nNOS/NO-Regulated Oxidative Stress, Yang Z, 2018
- Sesamin prevents apoptosis and inflammation after experimental myocardial infarction by JNK and NF-κB pathways, Yang Z, 2017
- Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy, Yang Z, 2017
- Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway, Yang Z, 2017
- A potential therapeutic approach to cardiac remodeling: JDP2, Yang Z, 2018
- Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy, Yang Z, 2016
- Naringenin attenuates pressure overload-induced cardiac hypertrophy, Yang Z, 2015
- Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes, Yang Z, 2014
- TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis, Yang Z, 2019
- TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy, Yang Z, 2020
- The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure, Yang Z, 2017
- Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis, Yang Z, 2016
- Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway, Yang Z, 2016
- Mechanisms contributing to cardiac remodelling, Yang Z, 2017
- BMI1 in the heart: Novel functions beyond tumorigenesis, Yang Z, 2021
- The Roles of Noncardiomyocytes in Cardiac Remodeling, Yang Z, 2020
- Critical roles of macrophages in pressure overload-induced cardiac remodeling, Yang Z, 2021
- 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway, Yang Z, 2021
Awards
- 2019 First Prize of Science and Technology Progress in Hubei Province for 'Structural Remodeling and Prevention of Heart Failure'
